New Research Suggests That Common HIV Drugs May Reduce Alzheimer’s Risk

Researchers at Sanford Burnham Prebys have discovered positive connections between certain HIV medications and Alzheimer’s disease.
Nearly seven million individuals in the U.S. are currently battling Alzheimer’s disease (AD), and projections suggest this number could rise to almost 13 million by 2050. This increasing prevalence highlights a critical gap in effective treatments for AD. Researchers at Sanford Burnham Prebys have recently made significant strides by discovering real-world evidence that common HIV medications may lower the risk of AD. The study, led by Jerold Chun, M.D., Ph.D., was published in Pharmaceuticals.